Patent details
EP2882450
Title:
FACTOR VIII COMPLEX WITH XTEN AND VON WILLEBRAND FACTOR PROTEIN, AND USES THEREOF
Basic Information
- Publication number:
- EP2882450
- PCT Application Number:
- US2013049989
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP138160312
- PCT Publication Number:
- WO2014011819
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- FACTOR VIII COMPLEX WITH XTEN AND VON WILLEBRAND FACTOR PROTEIN, AND USES THEREOF
- French Title of Invention:
- COMPLEXE DU FACTEUR VIII AVEC UNE SÉQUENCE XTEN ET LA PROTÉINE FACTEUR DE VON WILLEBRAND, ET UTILISATIONS ASSOCIÉES
- German Title of Invention:
- FAKTOR-VIII-KOMPLEX MIT XTEN UND VON-WILLEBRAND-FAKTOR-PROTEIN SOWIE VERWENDUNGEN DAVON
- SPC Number:
-
Dates
- Filing date:
- 10/07/2013
- Grant date:
- 27/11/2019
- EP Publication Date:
- 17/06/2015
- PCT Publication Date:
- 16/01/2014
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 27/11/2019
- EP B1 Publication Date:
- 27/11/2019
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 10/07/2033
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 20/11/2019
-
-
- Name:
- Bioverativ Therapeutics Inc.
- Address:
- 225 Second Avenue, Waltham, MA 02451, United States (US)
Agent
- Name:
- ARONOVA S.A.
- From:
- 20/01/2020
- Address:
- PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
- To:
Inventor
1
- Name:
- PETERS, Robert, T.
- Address:
- United States (US)
2
- Name:
- KULMAN, John
- Address:
- United States (US)
3
- Name:
- CHANG, Pei-yun
- Address:
- United States (US)
4
- Name:
- CHHABRA, Ekta, Seth
- Address:
- United States (US)
5
- Name:
- LIU, Tongyao
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201261670401 P
- Priority Date:
- 11/07/2012
- Priority Country:
- United States (US)
2
- Priority Number:
- 201361759819 P
- Priority Date:
- 01/02/2013
- Priority Country:
- United States (US)
3
- Priority Number:
- 201361801544 P
- Priority Date:
- 15/03/2013
- Priority Country:
- United States (US)
4
- Priority Number:
- 201361801504 P
- Priority Date:
- 15/03/2013
- Priority Country:
- United States (US)
5
- Priority Number:
- 201361827158 P
- Priority Date:
- 24/05/2013
- Priority Country:
- United States (US)
6
- Priority Number:
- 201361840811 P
- Priority Date:
- 28/06/2013
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 38/36;
A61K 38/37;
C07K 14/755;
C12N 15/00;
C12N 15/62;
C12P 21/08;
Publication
European Patent Bulletin
1
- Issue number:
- 201948
- Publication date:
- 27/11/2019
- Description:
- Grant (B1)
2
- Issue number:
- 201952
- Publication date:
- 25/12/2019
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 31/07/2026
- Annual Fee Number:
- 14
- Annual Fee Amount:
- 198 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 25/06/2025
- Last Annual Fee Paid Number:
- 13
- Last Annual Fee Paid Amount:
- 180 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM